Brown Advisory Inc Humacyte, Inc. Transaction History
Brown Advisory Inc
- $75.5 Billion
- Q4 2024
A detailed history of Brown Advisory Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 13,129 shares of HUMA stock, worth $44,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,129
Previous 13,129
-0.0%
Holding current value
$44,244
Previous $71,000
7.04%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
172Shares Held
41MCall Options Held
553KPut Options Held
942K-
Black Rock Inc. New York, NY7.14MShares$24.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$18.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.61MShares$15.5 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA2.85MShares$9.6 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$7.2 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $347M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...